Omega-3

Amarin Pharma’s recent comments advising FDA not to allow synthetic omega-3 supplements to be dietary supplements is just one more case in which synthetic supplement ingredients are under fire.

In comments submitted to FDA, Amarin Pharma, maker of the omega-3 drug Vascepa, stated its intentions to file a citizen petition to FDA asserting that ethyl ester omega-3s are not legally allowed to be marketed as dietary supplements. 

A recent study published in the Annals of Internal Medicine is dismissive of dietary supplements for preventing mortality and improving cardiovascular disease outcomes. 

 The Orivo origin seal verifies the authenticity of omega-3 fish oil products through testing that determines the product’s marine oil source and origin.

Archer Daniels Midland Company, in collaboration with Qualitas Health, has unveiled a new line of Onavita Algal DHA and Almega EPA blends. 

FDA said it will allow food and supplement companies to use a qualified health claim linking omega-3 fatty acids EPA and DHA with blood pressure benefits.

The goal for softgel manufacturers when handling marine oils like fish and krill oil is to minimize oxidation at all costs.

In a new animal study, researchers tested the effects of a supplement combination of Kyowa Hakko’s Cognizin-brand citicoline and omega-3 fatty acid DHA (DSM’s life’sDHA brand) in mice who were subjected to bilateral common carotid artery occlusion, resulting in cerebral ischemia.

OmegaQuant’s Omega-3 Index and Prenatal DHA test kits are now registered in the European Union as in vitro medical devices and CE-marked.

Algae’s valuable nutrition stores are prized in today’s human health market.

Amarin Pharma Inc., maker of high-concentration EPA-only omega-3 drug Vascepa, has reached a settlement with omega-3 dietary supplement companies The Coromega Company, Inc., and Omax Health, Inc over complaints the drug company filed in October of 2018.

Here’s what the latest research shows about five of the market’s fastest-growing cognitive performance ingredients.

Amarin, maker of the omega-3 drug Vascepa, has failed in its attempt to get an investigation launched against several omega-3 dietary supplement products and suppliers.

A study recently published in Circulation is challenging our understanding about the effect high levels of omega-6 fatty acids have on human health. 

A recent study published in The Journal of Nutrition shows that fish oil supplementation during the third trimester of pregnancy increased gestational age, size of gestational age, and the birth weight of infants. 

The Global Organization for EPA and DHA Omega-3s (GOED) has launched the GOED Proud Member logo. 

The European Medicines Agency (EMA) has confirmed its previous recommendation to no longer recommend the use of omega-3 fatty acids for secondary prevention of myocardial infarction, following a request for re-examination.

The heart health category remains important to the dietary supplement industry because it includes a stable of products that have proven efficacy and consistent usage.

Researchers determined that an absolute decrease in 1% of Omega-3 Index was associated with 39% greater odds of PAD.

Lycored will be developing a new formulation combining its Lycomato lycopene with omega-3 fatty acids. 

OmegaQuant Analytics is offering free Omega-3 Index tests at Natural Products Expo West booth #4568 where they are colocated with Wiley’s Finest. 

The single-use format makes it easy and convenient for consumers to carry their omega-3 supplements on the go.

The botanicals market is seeing a number of new entrants and emerging stars quickly gaining ground.

Market research indicates that today’s consumers are spending more on immune-health supplements than ever. Ahead, a look at some of the latest studies on immune-health ingredients.

According to the report, the global omega-3 sector grew 1.8% between 2016 and 2017, to become a $1.29 billion industry, experiencing its third straight year of growth.